Increased anticonvulsant effect of phenytoin in aging BDF1 mice. 1984

K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo

The anticonvulsant effect of phenytoin was examined in BDF1 mice of both sexes and various ages (6, 12, 24 and 30 months old) using the abolition of the tonic hindlimb extensor component of maximal electroshock seizure as the index. The minimal effective plasma concentration of phenytoin was significantly lower in 24- and 30-month-old mice compared with young adult (6 month old) mice. Similarly, all older groups (24 and 30 month old, both sexes) showed significantly lower minimal effective brain concentrations compared with respective younger (6 and 12 month old) animal groups. Studies using nearly 2-fold different intensities of electroshock (30 and 55 mA) showed almost identical results. The results provide evidence that, in adult mice, the brain becomes more sensitive with age to phenytoin with regard to its anticonvulsant effect.

UI MeSH Term Description Entries
D008297 Male Males
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive
D005260 Female Females
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
July 1988, The American journal of pathology,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
June 1993, Acta pathologica japonica,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
August 1973, Archives internationales de pharmacodynamie et de therapie,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
November 2018, International journal of pharmaceutics,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
February 1997, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
July 1993, Pharmaceutical research,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
January 2013, Pharmacological reports : PR,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
January 1979, Journal of pharmaceutical sciences,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
September 1985, The New England journal of medicine,
K Kitani, and Y Masuda, and Y Sato, and S Kanai, and M Ohta, and M Nokubo
March 1998, Epilepsy research,
Copied contents to your clipboard!